Clinical and research tests for C4016951 - Genetic Testing Registry (GTR) - NCBI

Warning: The NCBI web site requires JavaScript to function. more...

<< First < Prev

Page 2 of 4

Results: 21 to 40 of 72

Tests names and labs	Conditions	Genes, analytes, and microbes	Methods
TP53 sequencing and deletion/duplication Children's Hospital of Los Angeles, Center for Personalized Medicine United States	6	1	D Deletion/duplication analysis C Sequence analysis of the entire coding region
Hereditary breast/ovarian cancer - analysis the BRCA1 gene mutations in accordance with EMQN recommendations Laboratory of Human Genetics GENOMED Health Care Center Poland	6	1	C Sequence analysis of the entire coding region
Hereditary breast/ovarian cancer - analysis the BRCA2 gene mutations in accordance with EMQN recommendations Laboratory of Human Genetics GENOMED Health Care Center Poland	6	1	C Sequence analysis of the entire coding region
Inherited Cancer Panel Dhiti Omics Technologies Private Ltd India	135	84	C Sequence analysis of the entire coding region
OncoGeneDx Custom Panel GeneDx United States	103	82	D Deletion/duplication analysis C Sequence analysis of the entire coding region
Common Cancer Management Panel GeneDx United States	56	37	D Deletion/duplication analysis C Sequence analysis of the entire coding region
Breast Cancer Management Panel GeneDx United States	24	9	D Deletion/duplication analysis C Sequence analysis of the entire coding region
Breast/Gyn Cancer Panel GeneDx United States	46	24	D Deletion/duplication analysis C Sequence analysis of the entire coding region
Comprehensive Common Cancer Panel GeneDx United States	60	47	D Deletion/duplication analysis C Sequence analysis of the entire coding region
ACMG Secondary Findings (Medically Actionable Genes, Including Cardio and Cancer) NGS Panel Fulgent Genetics United States	177	59	D Deletion/duplication analysis C Sequence analysis of the entire coding region
Breast and Ovarian Cancer Focus Panel Fulgent Genetics United States	50	21	D Deletion/duplication analysis C Sequence analysis of the entire coding region
Breast Cancer STAT Fulgent Genetics United States	34	9	D Deletion/duplication analysis C Sequence analysis of the entire coding region
Breast and Ovarian Cancer Comprehensive Panel Fulgent Genetics United States	58	24	D Deletion/duplication analysis C Sequence analysis of the entire coding region
Full Focus Cancer Panel Fulgent Genetics United States	82	30	D Deletion/duplication analysis C Sequence analysis of the entire coding region
Invitae Pediatric Solid Tumors Panel Invitae United States	90	48	D Deletion/duplication analysis C Sequence analysis of the entire coding region
Invitae Breast Cancer STAT Panel Invitae United States	17	7	D Deletion/duplication analysis C Sequence analysis of the entire coding region
BRCA 1 and BRCA2 Gene Sequencing Center for Comprehensive Genetic Services Shahid Beheshti University of Medical Sciences Iran	4	2	D Deletion/duplication analysis S Mutation scanning of the entire coding region C Sequence analysis of the entire coding region
Renal / Urinary Cancer Comprehensive Panel Fulgent Genetics United States	73	27	D Deletion/duplication analysis C Sequence analysis of the entire coding region
Sarcoma Comprehensive Panel Fulgent Genetics United States	70	26	D Deletion/duplication analysis C Sequence analysis of the entire coding region
Prostate Cancer Comprehensive Panel Fulgent Genetics United States	29	12	D Deletion/duplication analysis C Sequence analysis of the entire coding region

<< First < Prev

Page 2 of 4

Results: 21 to 40 of 72

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.